Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease-Reference-Cited by-同舟云学术

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Published:2017-05-04 Issue:18 Volume:376 Page:1713-1722
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Sabatine Marc S.,Giugliano Robert P.,Keech Anthony C.,Honarpour Narimon,Wiviott Stephen D.,Murphy Sabina A.,Kuder Julia F.,Wang Huei,Liu Thomas,Wasserman Scott M.,Sever Peter S.,Pedersen Terje R.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1615664

Cited by 4061 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive retrospect on biomarkers indicating vascular failure;Vascular Failure;2024-12-01

2. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

3. Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design;American Heart Journal;2024-11

4. Leonurine improves atherosclerosis by activating foam cell autophagy and metabolic remodeling via METTL3-mediated AKT1S1 mRNA stability modulation;Phytomedicine;2024-11

5. PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study;American Heart Journal;2024-11